Key result
Switching from warfarin to low-molecular-weight heparin in a pregnant woman with a mechanical mitral valve resulted in acute valve thrombosis and life-threatening pulmonary edema at gestational week 24.
Why the study?
Is low-molecular-weight heparin a safe alternative to warfarin for anticoagulation in pregnant women with mechanical heart valves?
Case Report (n=1)
Is low-molecular-weight heparin a safe alternative to warfarin for anticoagulation in pregnant women with mechanical heart valves?
LMWH may be associated with a high risk of valve thrombosis when used as an alternative to warfarin in pregnant women with mechanical heart valves.
Answers are grounded in this paper and cite their sources.
LMWH substitution may carry high thrombosis risk in pregnant women with mechanical mitral valves; leaves open the safest anticoagulation approach.
We report on the treatment failure of low molecular weight heparin (LMWH) for anticoagulation in a pregnant woman that underwent artificial mitral valve replacement 10 years prior to her pregnancy. Until she became pregnant warfarin was administered for anticoagulation, but due to the often mentioned increased risk for warfarin-induced maternal and fetal complications, at gestational week 5 the anticoagulation regimen was switched to subcutaneous application of low molecular weight heparin. At gestational week 24 our patient developed acute life-threatening pulmonary edema and hemodynamic instability due to acute mitral valve thrombosis and underwent emergency valve re-replacement with a biological porcine valve. She recovered uneventfully and gave birth to a healthy child at gestational week 35. In addition to our case presentation we review the sparse evidence in the literature regarding anticoagulation in pregnant women with mechanical heart valves and discuss the rational of different anticoagulation regimens with regards to maternal and fetal outcome. Special consideration is directed towards LMWH administration as an alternative to oral anticoagulation during pregnancy in women with mechanical heart valves.
No takes yet. Share an insight, caveat, or question.
Rainer Leyh (2002) conducted a case report in Pregnancy with mechanical mitral valve (n=1). Low molecular weight heparin (LMWH) vs. Warfarin was evaluated on Treatment failure (acute mitral valve thrombosis). Switching from warfarin to low-molecular-weight heparin in a pregnant woman with a mechanical mitral valve resulted in acute valve thrombosis and life-threatening pulmonary edema at gestational week 24.
Synapse has enriched 10 related papers. Consider them for comparative context: